Call to arrange a consultation
+1 416 777 0888

Axcan Pharma Inc. v. Pharmascience Inc.

Represented Pharmascience Inc. in a proceeding under the Patented Medicines (Notice of Compliance) Regulations regarding the invalidity and non-infringement of a patent relating to Axcan's Urso (ursodiol) product.  The dismissal of Axcan's application is reported at 2005 FC 1231.

Meet the team